breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participate voluntarily and sign the informed consent in writing; 2. Female, aged 18-70; 3. All patients underwent mastectomy, and the postoperative pathology was invasive carcinoma; 4. Immediately implant a dilator after glandular resection; 5. Normal blood routine test, liver and kidney function; 6. There is no serious underlying disease in the heart and lungs.
Exclusion criteria
Exclusion criteria: 1. Patients whose breast gland resection is more than 8 months away from the start of adjuvant radiotherapy; 2. HER-2 positive patients without targeted treatment; 3. Patients who did not complete postoperative adjuvant chemotherapy as planned; 4. Patients with ER/PR positive and without postoperative adjuvant endocrine therapy; 5. Patients with distant metastasis; 6. The area to be irradiated has a history of previous radiotherapy; 7. Patients with active connective tissue disease in the treatment area; 8. Patients with serious complications; 9. Patients with an estimated survival period of less than 12 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cellulitis;hematoma;subcutaneous hematoma;effusion;skin flap necrosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| locoregional relapse;overal survival; | — |
Countries
China
Contacts
First Medical Center of Chinese PLA General Hospital